Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Parry

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Archives of Disease in Childhood|December 25, 2008
Epidemiology of critically ill children in England and Wales: incidence, mortality, deprivation and ethnicityR C Parslow, R C Tasker, E S Draper, et al.
Electromyography and Clinical Neurophysiology|December 1, 1991
Clinical and electrophysiological assessments in ALS patientsA J Tahmoush, J A Gillespie, J F Hulihan, et al.
Journal of the Neurological Sciences|January 7, 1998
A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study GroupD McGuire, L Garrison, C Armon, et al.
Muscle & Nerve|September 1, 1991
Conduction block in clinical practiceD R Cornblath, A J Sumner, J Daube, et al.
Neurology|March 17, 1999
Limitations of quantitative sensory testing when patients are biased toward a bad outcomeD Yarnitsky, E Sprecher, R Zaslansky, et al.
Muscle & Nerve|June 1, 1997
Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study GroupR J Hoagland, M Mendoza, C Armon, et al.
Annals of Neurology|February 1, 1996
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study GroupR G Miller, J H Petajan, W W Bryan, et al.
Annals of Neurology|October 1, 1990
Peripheral neuropathy associated with eosinophilia-myalgia syndromeT D Heiman-Patterson, S J Bird, G J Parry, et al.
Neurology|March 26, 2003
Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM E Shy, E M Frohman, Y T So, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|May 15, 2003
Can we eliminate placebo in ALS clinical trials?W W Bryan, R J Hoagland, J Murphy, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Archives of Disease in Childhood|December 25, 2008
Epidemiology of critically ill children in England and Wales: incidence, mortality, deprivation and ethnicityR C Parslow, R C Tasker, E S Draper, et al.
Electromyography and Clinical Neurophysiology|December 1, 1991
Clinical and electrophysiological assessments in ALS patientsA J Tahmoush, J A Gillespie, J F Hulihan, et al.
Journal of the Neurological Sciences|January 7, 1998
A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study GroupD McGuire, L Garrison, C Armon, et al.
Muscle & Nerve|September 1, 1991
Conduction block in clinical practiceD R Cornblath, A J Sumner, J Daube, et al.
Neurology|March 17, 1999
Limitations of quantitative sensory testing when patients are biased toward a bad outcomeD Yarnitsky, E Sprecher, R Zaslansky, et al.
Muscle & Nerve|June 1, 1997
Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study GroupR J Hoagland, M Mendoza, C Armon, et al.
Annals of Neurology|February 1, 1996
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study GroupR G Miller, J H Petajan, W W Bryan, et al.
Annals of Neurology|October 1, 1990
Peripheral neuropathy associated with eosinophilia-myalgia syndromeT D Heiman-Patterson, S J Bird, G J Parry, et al.
Neurology|March 26, 2003
Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyM E Shy, E M Frohman, Y T So, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|May 15, 2003
Can we eliminate placebo in ALS clinical trials?W W Bryan, R J Hoagland, J Murphy, et al.
Pageof 8